Q3 2024

Filed Nov 13, 2024 · 10-Q · 44 days after period end · 0001437749-24-034956

Q3 2024 · 10-Q

Revenue

$0.00

— vs Q3 2023

Net Income

-$290.00K

N/M vs Q3 2023

EPS, diluted—

Operating Income-$387,000N/M

Operating Cash Flowderived-$72,000N/M

Same quarter

Metric	Q3 2024	Q3 2023	Q3 2022	Q3 2021
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$290.00K	-$127.00K	-$321.00K	-$352.00K
EPS Diluted	—	-$0.02	-$0.04	-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Elite Health Systems Inc. · CIK 1089815 · Engraved from SEC EDGAR